- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06117943
Pregnant Women's Knowledge of the Active and Passive Smoking Effects on Pregnancy and the Fetus (tabac-GO)
There are two remaining areas where the standards for tobacco use during pregnancy have changed little: one area is the high level of consumption by pregnant women and the other is the limited care given to pregnant women.
Indeed, many pregnant women are still over-exposed to tobacco, either through personal use or passive exposure to cigarette smoke. This passive exposure often comes from the consumption of their loved ones, such as their future co-parent or family.
However, throughout our lives, health professionals, associations, and the government send a lot of information and messages about the negative effects of tobacco on health, pregnancy, and the fetus.
This information and the possibility of receiving help from a professional trained in tobacco use exist throughout the entire pregnancy.
However, many women and their partners still do not take the necessary precautions to reduce or stop smoking. Do couples who smoke during pregnancy really have an understanding of the smoking's effects on women and their fetuses? Could they realize it and would they reduce or stop their consumption, in case they knew these negative effects?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aims are:
- To describe the knowledge of pregnant women who smoke or are exposed to tobacco smoke about the effects of active and passive smoking on the obstetrical and fetal systems.
- To identify the information that has been received by pregnant women who smoke or are confronted with tobacco smoke about the effects of tobacco on pregnancy.
- To identify information sources for pregnant women who smoke or are exposed to tobacco smoke about the negative effects of tobacco on pregnancy.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Reims, France, 51100
- Ufr Medecine Urca
-
Reims, France, 51100
- Université de Reims Champagne Ardenne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- pregnant women after 32 weeks of amenorrhea
- Primigravida women
- women exposed to passive or active smoking
- women aged over 18 years
- Accepting to participate in the study
Exclusion Criteria:
- Minors
- protected by law (guardianship, custodianship, judicial protection)
- refusing to participate in the study
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pregnant women
Pregnant women who smoke personally or are passively exposed to cigarette smoke
|
Pregnant women who smoke personally or are passively exposed to cigarette smoke
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
smoking effects on pregnancy questionnaire
Time Frame: day0
|
Pregnant women's knowledge of the active and passive smoking effects on pregnancy : does the woman know or not risk of miscarriage, ectopic pregnancy, premature birth, premature rupture of membranes, low-lying placenta and retro-placental hematoma associated with smoking
|
day0
|
|
smoking effects on the fetus questionnaire
Time Frame: day0
|
Pregnant women's knowledge of the active and passive smoking effects on the fetus : does the woman know or not risk of premature birth, growth delay, malformation, sudden infant death syndrome associated with smoking
|
day0
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2023_RIPH_013_tabac-GO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnant Women's Tabacco Exposure
-
Amasya UniversityNot yet recruitingPregnant Women | Women's Health | Childbirth
-
Eunice Kennedy Shriver National Institute of Child...CompletedLead Exposure in Pregnant Women | Tobacco Smoke Exposure Pregnant WomenUnited States
-
Serap Ozturk AltinayakActive, not recruitingThe Status of Pregnant Women's Breastfeeding Health LiteracyTurkey (Türkiye)
-
Atlas UniversityRecruitingThe Effect of Couples' Participation in Childbirth Preparation Education on Pregnant Women's Perceived Spousal Support, Fear of Childbirth, and Self-EfficacyTurkey
-
University of North Carolina, Chapel HillGilead Sciences; Duke UniversityCompletedPrEP | HIV Prevention | Women's Health | Prevention | Mobile Health | Pre-exposure ProphylaxisUnited States
-
Centre Hospitalier de GonesseCompletedVaccinate Against Covid-19 | Reluctance Pregnant Women'sFrance
-
Fenerbahce UniversityCompletedTelemedicine | Pregnant Women | Women's Health | COVID-19 Pandemic | Family Planning ServicesTurkey
Clinical Trials on data collection
-
Care Management PlusCompletedHealth Information Technology | Nurse Based Care ManagementUnited States
-
GCS Ramsay Santé pour l'Enseignement et la RechercheCompleted
-
M.D. Anderson Cancer CenterUnknownPediatric CancerUnited States
-
GlaxoSmithKlineCompletedInfections, StreptococcalRomania, Slovenia, Poland, Lithuania, Estonia
-
Hospices Civils de LyonCompleted
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompleted
-
Xuanwu Hospital, BeijingRecruitingMultiple Sclerosis | Myasthenia Gravis | Autoimmune Encephalitis | Acute Disseminated Encephalomyelitis | NMO Spectrum Disorder | Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseChina
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingCerebrospinal; DisorderFrance
-
Women and Infants Hospital of Rhode IslandTerminated
-
Centre Hospitalier Universitaire DijonCompletedCoronary Artery Bypass Graft | Anomalies in Glucose MetabolismFrance